192 related articles for article (PubMed ID: 21601254)
1. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
[TBL] [Abstract][Full Text] [Related]
2. Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery.
Strope SA; Wei JT; Smith A; Wilt TJ; Saigal CS; Elliott SP;
Urology; 2012 Jul; 80(1):84-9. PubMed ID: 22608799
[TBL] [Abstract][Full Text] [Related]
3. Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.
Strope SA; Elliott SP; Smith A; Wei JT; Wilt TJ; Saigal CS;
Urology; 2011 Mar; 77(3):535-40. PubMed ID: 21256570
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
[TBL] [Abstract][Full Text] [Related]
5. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
[TBL] [Abstract][Full Text] [Related]
8. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
[TBL] [Abstract][Full Text] [Related]
9. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
Barry MJ; Fowler FJ; Bin L; Oesterling JE
J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
[TBL] [Abstract][Full Text] [Related]
10. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
Nickel JC; Saad F
Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
[TBL] [Abstract][Full Text] [Related]
11. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council.
Ramsey EW; Elhilali M; Goldenberg SL; Nickel CJ; Norman R; Perreault JP; Piercy B; Trachtenberg J
J Urol; 2000 Feb; 163(2):499-502. PubMed ID: 10647665
[TBL] [Abstract][Full Text] [Related]
12. CROATIAN UROLOGISTS' CLINICAL PRACTICE AND COMPLIANCE WITH GUIDELINES IN THE MANAGEMENT OF NON-NEUROGENIC MALE LOWER URINARY TRACT SYMPTOMS.
Tomasković I; Tomić M; Nikles S; Neretljak I; Milicić V
Acta Clin Croat; 2015 Dec; 54(4):453-7. PubMed ID: 27017719
[TBL] [Abstract][Full Text] [Related]
13. Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation.
Bellinger AS; Elliott SP; Yang L; Wei JT; Saigal CS; Smith A; Wilt TJ; Strope SA;
J Urol; 2012 May; 187(5):1739-46. PubMed ID: 22425128
[TBL] [Abstract][Full Text] [Related]
14. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States.
Clemens JQ; Goldman HB; Zou KH; Luo X; Russell D; Chapman DS; Esinduy CB; Anger JT
J Urol; 2016 Jul; 196(1):173-8. PubMed ID: 26872842
[TBL] [Abstract][Full Text] [Related]
16. 1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.
Gee WF; Holtgrewe HL; Blute ML; Miles BJ; Naslund MJ; Nellans RE; O'Leary MP; Thomas R; Painter MR; Meyer JJ; Rohner TJ; Cooper TP; Blizzard R; Fenninger RB; Emmons L
J Urol; 1998 Nov; 160(5):1804-7. PubMed ID: 9783961
[TBL] [Abstract][Full Text] [Related]
17. Management of symptomatic BPH in Italy: who is treated and how?
Tubaro A; Montanari E
Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
[TBL] [Abstract][Full Text] [Related]
18. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care.
Strope SA
Curr Opin Urol; 2018 May; 28(3):262-266. PubMed ID: 29601306
[TBL] [Abstract][Full Text] [Related]
20. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
